Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

9.78

+0.53 (5.73%)

At close: Aug 21, 2026, 4:00 PM EDT

9.70

-0.08 (-0.82%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	446	478.39	519.85	615.1	905.45	1,431
Short-Term Investments	-	2.4	6.14	13.41	2.09	65.63
Cash & Short-Term Investments	446	480.79	525.99	628.5	907.55	1,497
Cash Growth	-9.93%	-8.59%	-16.31%	-30.75%	-39.37%	-33.84%
Accounts Receivable	177.21	181.91	165.87	149.61	151.71	134.59
Other Receivables	-	0.07	0.18	1.18	0.1	0.11
Receivables	177.21	181.98	166.05	150.79	151.81	138.2
Inventory	54.29	56.98	62.63	69.02	130.32	123.21
Restricted Cash	2.73	2.7	2.31	0.12	19.82	7.8
Other Current Assets	20.76	16.14	19.65	35.67	49.27	54.79
Total Current Assets	701	738.59	776.62	884.1	1,259	1,821
Property, Plant & Equipment	78.93	73.87	100.34	144.2	300.03	406.45
Long-Term Investments	-	-	-	0.34	0.69	0.91
Other Intangible Assets	0.26	0.28	0.42	0.96	1.99	5.15
Other Long-Term Assets	7.6	7.63	7.93	5.09	20.89	45.14
Total Assets	787.78	820.38	885.31	1,040	1,587	2,279

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	18.04	40.74	33.75	18.06	50.95	63.08
Accrued Expenses	75.38	51.99	56.71	65.37	104.23	107.03
Short-Term Debt	-	-	-	-	-	2.37
Current Portion of Long-Term Debt	0.2	0.2	-	-	-	-
Current Portion of Leases	21.11	16.76	24.57	8.63	37.24	35
Current Income Taxes Payable	-	16.38	14.46	20.62	11.03	7.69
Current Unearned Revenue	114.49	107.82	117.9	130.54	147.63	142.87
Other Current Liabilities	0.59	13.09	18.92	20.14	60.38	14.14
Total Current Liabilities	229.82	246.98	266.3	263.36	411.45	372.18
Long-Term Debt	1.7	1.7	-	-	-	-
Long-Term Leases	27.85	24.46	27.75	3.69	13.55	49.32
Other Long-Term Liabilities	11.96	11.98	10.43	4.54	4.12	11.78
Total Liabilities	271.33	285.11	304.48	271.59	429.13	433.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.14	0.14	0.15	0.14	0.14	0.14
Additional Paid-In Capital	5,012	5,010	5,002	4,849	4,583	4,281
Retained Earnings	-4,273	-4,256	-4,200	-3,854	-3,200	-2,229
Treasury Stock	-57.19	-57.19	-63.26	-65.9	-58.92	-
Comprehensive Income & Other	-165.28	-162.14	-158.05	-161.53	-165.72	-207.07
Total Common Equity	516.46	535.26	580.83	768.41	1,158	1,845
Shareholders' Equity	516.46	535.26	580.83	768.41	1,158	1,845
Total Liabilities & Equity	787.78	820.38	885.31	1,040	1,587	2,279

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	50.86	43.12	52.32	12.32	50.79	86.69
Net Cash (Debt)	395.14	437.67	473.66	616.18	856.76	1,410
Net Cash Growth	-12.74%	-7.60%	-23.13%	-28.08%	-39.25%	-36.35%
Net Cash Per Share	37.38	41.17	46.02	60.18	82.45	135.33
Filing Date Shares Outstanding	10.52	10.55	10.77	10.26	10.27	10.52
Total Common Shares Outstanding	10.52	10.52	10.76	10.24	10.26	10.51
Working Capital	471.18	491.61	510.32	620.73	847.31	1,449
Book Value Per Share	49.09	50.89	53.97	75.01	112.85	175.56
Tangible Book Value	516.2	534.98	580.41	767.45	1,156	1,840
Tangible Book Value Per Share	49.07	50.86	53.93	74.92	112.66	175.07
Machinery	-	301.41	307.49	348.07	339.09	297.89
Construction In Progress	-	0.63	0.63	0.55	2.66	27.56
Leasehold Improvements	-	187.03	187.23	187.39	187.38	161.04

SEC Filings: 10-K · 10-Q